AIM: in preclinical models. MATERIALS AND METHODS: infections with survival outcomes. Data were pooled using a fixed-effects model, with subgroup and sensitivity analyses. PROTOCOL REGISTRATION: www.crd.york.ac.uk/prospero identifier is CRD420251059693. CONCLUSION: . It represents a rapid, targeted, and antibiotic-sparing approach, supporting future antimicrobial stewardship efforts and informing the design of clinical applications.
No takes yet. Share an insight, caveat, or question.
Sadeghi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: